These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 30569843)

  • 21. Anti-inflammatory effects of flavonoids.
    Maleki SJ; Crespo JF; Cabanillas B
    Food Chem; 2019 Nov; 299():125124. PubMed ID: 31288163
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cardiovascular receptors as drug targets. Eur omega Conferences' Cardiovascular receptors as drug targets. Institut Pasteur, Paris, France, 3-4 October 1996.
    Maack T
    Mol Med Today; 1997 Mar; 3(3):101-2. PubMed ID: 9095483
    [No Abstract]   [Full Text] [Related]  

  • 23. Effects of imperatorin in the cardiovascular system and cancer.
    Nasser MI; Zhu S; Hu H; Huang H; Guo M; Zhu P
    Biomed Pharmacother; 2019 Dec; 120():109401. PubMed ID: 31622950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Vascular Pathways of Testosterone: Clinical Implications.
    Lorigo M; Mariana M; Oliveira N; Lemos MC; Cairrao E
    J Cardiovasc Transl Res; 2020 Feb; 13(1):55-72. PubMed ID: 31820333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Flavonoids, vascular function and cardiovascular protection.
    Grassi D; Desideri G; Croce G; Tiberti S; Aggio A; Ferri C
    Curr Pharm Des; 2009; 15(10):1072-84. PubMed ID: 19355949
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tea flavonoids and cardiovascular health.
    Hodgson JM; Croft KD
    Mol Aspects Med; 2010 Dec; 31(6):495-502. PubMed ID: 20837049
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.
    Henning RJ; Bourgeois M; Harbison RD
    Cardiovasc Toxicol; 2018 Dec; 18(6):493-506. PubMed ID: 29968072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cranberry flavonoids, atherosclerosis and cardiovascular health.
    Reed J
    Crit Rev Food Sci Nutr; 2002; 42(3 Suppl):301-16. PubMed ID: 12058989
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cardiovascular autophagy: crossroads of pathology, pharmacology and toxicology.
    Salabei JK; Conklin DJ
    Cardiovasc Toxicol; 2013 Sep; 13(3):220-9. PubMed ID: 23408289
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Effects of Flavonoids in Cardiovascular Diseases.
    Ciumărnean L; Milaciu MV; Runcan O; Vesa ȘC; Răchișan AL; Negrean V; Perné MG; Donca VI; Alexescu TG; Para I; Dogaru G
    Molecules; 2020 Sep; 25(18):. PubMed ID: 32967119
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases.
    Zordoky BN; Robertson IM; Dyck JR
    Biochim Biophys Acta; 2015 Jun; 1852(6):1155-77. PubMed ID: 25451966
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Red wine consumption and prevention of atherosclerosis: an in vitro model using human peripheral blood mononuclear cells.
    Magrone T; Tafaro A; Jirillo F; Panaro MA; Cuzzuol P; Cuzzuol AC; Pugliese V; Amati L; Jirillo E; Covelli V
    Curr Pharm Des; 2007; 13(36):3718-25. PubMed ID: 18220811
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New Sides of Aldosterone Action in Cardiovascular System as Potential Targets for Therapeutic Intervention.
    Kolodziejczyk P; Gromotowicz-Poplawska A; Aleksiejczuk M; Chabielska E; Tutka P; Miltyk W
    Curr Drug Targets; 2018; 19(16):1968-1979. PubMed ID: 29577853
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Modulation of platelet function and signaling by flavonoids.
    El Haouari M; Rosado JA
    Mini Rev Med Chem; 2011 Feb; 11(2):131-42. PubMed ID: 21222578
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cardiovascular effects and molecular targets of resveratrol.
    Li H; Xia N; Förstermann U
    Nitric Oxide; 2012 Feb; 26(2):102-10. PubMed ID: 22245452
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Cardiovascular effects of chocolate.
    Garcia JP; Santana A; Baruqui DL; Suraci N
    Rev Cardiovasc Med; 2018 Dec; 19(4):123-127. PubMed ID: 31064163
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protective effects of dark chocolate on endothelial function and diabetes.
    Grassi D; Desideri G; Ferri C
    Curr Opin Clin Nutr Metab Care; 2013 Nov; 16(6):662-8. PubMed ID: 24100673
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mechanistic insights into the vascular effects of blueberries: Evidence from recent studies.
    Cutler BR; Petersen C; Anandh Babu PV
    Mol Nutr Food Res; 2017 Jun; 61(6):. PubMed ID: 27558887
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Effects of geranylgeranylacetone upon cardiovascular diseases.
    Zeng S; Wang H; Chen Z; Cao Q; Hu L; Wu Y
    Cardiovasc Ther; 2018 Aug; 36(4):e12331. PubMed ID: 29656548
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Influence of sex on cardiovascular drug responses: role of estrogen.
    Abdel-Rahman AA
    Curr Opin Pharmacol; 2017 Apr; 33():1-5. PubMed ID: 28340373
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.